CRISPR THERAPEUTICS AG

Connections CRISPR Therapeutics AG

Stocks

CRSP

CH0334081137

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 11/07/2026 am IST			5-day change	1st Jan Change
53.35 ^USD	-5.31%		-11.20%	+1.74%

30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark	CI
30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark	CI

26

Listed companies

11

Private companies

56

Insiders

Relation chart of related listed companies: CRISPR Therapeutics AG

Active Relations

Past Relations

Related listed companies: CRISPR Therapeutics AG

INCYTE CORPORATION

REGENERON PHARMACEUTICALS, INC.

Christian Rommel

NORTHROP GRUMMAN CORPORATION

MILESTONE PHARMACEUTICALS INC.

Michael Tomsicek

LANTHEUS HOLDINGS, INC.

Phuong Khanh Morrow

Briggs Morrison

ABSCI CORPORATION

SHATTUCK LABS, INC.

BLACK DIAMOND THERAPEUTICS, INC.

Samarth Kulkarni

MOTUS GI HOLDINGS, INC.

VOR BIOPHARMA INC.

TSCAN THERAPEUTICS, INC.

Stephen Camiolo

DESIGN THERAPEUTICS, INC.

WEREWOLF THERAPEUTICS, INC.

Briggs Morrison

CENTURY THERAPEUTICS, INC.

DAMORA THERAPEUTICS, INC.

JADE BIOSCIENCES, INC.

ACRIVON THERAPEUTICS, INC.

Michael Tomsicek

MONTE ROSA THERAPEUTICS, INC.

SIONNA THERAPEUTICS, INC.

JASPER THERAPEUTICS, INC.

Kurt von Emster

UPSTREAM BIO, INC.

SPYGLASS PHARMA, INC.

Active Relations

Past Relations

Relationship chart for related private companies: CRISPR Therapeutics AG

Active Relations

Past Relations

Related private companies: CRISPR Therapeutics AG

Biotechnology Innovation Organization

Miscellaneous Commercial Services

GSK Equity Investments Ltd.

Investment Managers

Versant Venture Management LLC

Investment Managers

Council on Foreign Relations, Inc.

Investment Trusts/Mutual Funds

Bird Rock Bio Sub, Inc.

Biotechnology

Inception IBD, Inc.

Miscellaneous Commercial Services

Versant Venture Capital VI (Canada) LP

Investment Managers

Jecure Therapeutics, Inc.

Miscellaneous Commercial Services

ERS Genomics Ltd.

Biotechnology

Emmanuelle Charpentier

858 Therapeutics, Inc.

Biotechnology

Xap Therapeutics Ltd

Pharmaceuticals: Major

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Biotechnology	18
Pharmaceuticals: Major	9
Investment Managers	3
Miscellaneous Commercial Services	3
Medical Specialties	2
Aerospace & Defense	1
Investment Trusts/Mutual Funds	1

Countries of related companies

United States	32
United Kingdom	1
Ireland	1
Switzerland	1
Canada	1
Germany	1

Company Profile

CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Employees

393

Sector

Biotechnology & Medical Research

More about the company

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener